CompletedNot Applicable

Nutritional Supplements in Patients with Anorexia Nervosa

Spain42 participantsStarted 2021-10-15

Plain-language summary

Anorexia nervosa causes gastroparesis, constipation, and can lead to elevated liver enzymes. It is often necessary to supplement the diet of patients with nutritional formulas. The ingestion of a peptide formula, with partially hydrolyzed protein and rich in medium chain triglycerides, could favor its digestion and absorption, improving its tolerance and acceptance by the patient, compared to a polymeric formula.

Who can participate

Age range12 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male or female participants, ≥ 12 y ≤ 40 years of age at screening * Diagnosed of Anorexy nervous according to DSM-5 * Appropiate cultural level \& understanding of the clinical study * To be in agreement in participate voluntarily in the study and written informed consent must be obtained from the participants. * Females who are non-pregnant and non-lactating women or women who have given birth at least six weeks before to the screening visit. Exclusion Criteria: * Allergy or intolerance to any component of the products under study. * Participation in a concomitant trial that conflicts with this study * Doesn't sign the informed consent

What they're measuring

Compare the digestive tolerance of an oligomeric nutritional supplement with respect to a polymeric nutritional supplement in a group of patients diagnosed with anorexia nervosa under follow-up by the Nutrition Unit.

Timeframe: From baseline to week 1

Trial details

NCT IDNCT05184738

SponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-03-12

View on ClinicalTrials.gov More Anorexia Nervosa trials